Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Blood Advances|February 5, 2025
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomasDai Chihara, Raphael E Steiner, Ranjit Nair, et al.
Blood Advances|June 15, 2025
A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphomaNeha Akkad, Lei Feng, Jason R Westin, et al.
Haematologica|November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAndrew P Jallouk, Naishu Kui, Ryan Sun, et al.
Frontiers in Oncology|September 26, 2024
Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organsGohar S Manzar, Elaine E Cha, Kelsey L Corrigan, et al.
Leukemia & Lymphoma|January 24, 2020
Pretreatment SUV<sub>max</sub> may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FLPaolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Leukemia & Lymphoma|May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapyKarine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
Haematologica|October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-RBrian Hess, Alison Moskowitz, James A Davis, et al.
Blood|January 24, 2018
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomideKoichi Takahashi, Boyu Hu, Feng Wang, et al.
Haematologica|November 14, 2024
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centersViktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, et al.
Pageof 16